New treatments for vulvovaginal candidiasis
openaire +2 more sources
SGLT2 Inhibitors in Clinical Practice: Cardiorenal Benefits and Risk of Fungal Infections-A Nephrologist's Perspective. [PDF]
Andryszkiewicz W +3 more
europepmc +1 more source
Navigating diagnostic uncertainty in vulvar lichen sclerosus: When clinical and histopathologic findings diverge. [PDF]
Kadam P, Pomeranz MK, Lipner SR.
europepmc +1 more source
An IL-1, IL-17, and IL-22 cytokine circuit controls vulvovaginal candidiasis independently of estrogen. [PDF]
Coleman BM +14 more
europepmc +1 more source
Protective effects of <i>Lactiplantibacillus plantarum</i> YC225 Mixture Are associated with Gut Microbiota in Vulvovaginal Candidiasis. [PDF]
Kim HJ +8 more
europepmc +1 more source
Characterization of the vaginal microbiome and its metabolic potential in Colombian patients with recurrent vulvovaginal candidiasis. [PDF]
Consuegra-Asprilla JM +2 more
europepmc +1 more source
Fluconazole-Induced Fixed Drug Eruption With Cross-Reactivity to Clotrimazole-Confirmation With Patch Testing. [PDF]
Sron DS +4 more
europepmc +1 more source
Vulvovaginal candidiasis and antifungal susceptibility pattern of isolated Candida spp. among women in Aden Governorate, Yemen. [PDF]
Gubran ANM +2 more
europepmc +1 more source
Advances in vulvovaginal candidiasis research: a comprehensive review from epidemiology, diagnosis, treatment to resistance mechanisms. [PDF]
Zhu W, Guo L.
europepmc +1 more source

